Start Date
February 29, 2016
Primary Completion Date
August 31, 2017
Study Completion Date
November 30, 2017
ticagrelor
A platelet aggregation inhibitor
prasugrel
a thienopyridine class inhibitor of platelet activation and aggregation
Placebo
placebo
Baylor-St. Lukes Medical Center, Houston
Houston Methodist Hospital, Houston
Memorial Hermann Hospital, Houston
Collaborators (1)
AstraZeneca
INDUSTRY
Yochai Birnbaum
OTHER